Complement Factor D/Adipsin Antibody (110) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90630DL594
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
ELISA
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 110
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Mouse Complement Factor D/Adipsin (Uniprot#: P03953-2; Met1-Ser258).
Specificity
Has cross-reactivity in ELISA with: Human CFADNo cross-reactivity in ELISA with: Human CFH
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Complement Factor D/Adipsin Antibody (110) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Complement Factor D/Adipsin
Alternate Names
Adipsin, ADN, AMBP-1, CFD, PFD
Gene Symbol
CFD
Additional Complement Factor D/Adipsin Products
Product Documents for Complement Factor D/Adipsin Antibody (110) [DyLight 594]
Product Specific Notices for Complement Factor D/Adipsin Antibody (110) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...